. Author manuscript; available in PMC: 2013 Apr 22.

Published in final edited form as: J Pathol. 2011 Jun 14;224(4):540–552. doi: 10.1002/path.2891

Table 1.

Tumour spectrum in p53^+/− and p53^+/−:SFA/+ mice

	p53^+/− (n = 29)	p53^+/−:SFA/+ (n = 36)
Lymphoma	9 (23.7%)	9 (15.2%)
Sarcoma	21 (55.3%)	30 (50.8%)
Unclassified	8 (21.08%)	8^*¹ (13.5%)
Osteosarcoma	12^*¹ (31.6%)	21^*⁷ (35.6%)
Rhabdomyosarcoma	1 (2.6%)	1 (1.7%)
Carcinoma	6 (15.8%)	11 (18.6%)
Unclassified	0	1 (1.7%)
Squamous cell	5 (13.2%)	7 (11.8%)
Adenocarcinoma	1 (2.6%)	3^*¹ (5.1%)
Other	2 (5.3%)	9 (15.2%)
Adenoma	2 (5.3%)	3 (5.1%)
Lipoma	0	2 (3.4%)
Leiomyoma	0	1 (1.7%)
Plasmacytoma	0	2 (3.4%)
Haemangioma	0	1 (1.7%)
Tumours total	38	59
Tumours/mouse	1.31	1.64
Mice with multiple primaries	8 (27%)	12 (33%)
Metastasis	1 (3.7%)	9 (22%)
Metastasis from osteosarcoma	1 (8.3%)	8 (33.3%)

Number of tumours that metastasized.